Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease

American Journal of Cardiology

Volumn 92, Issue 10, 2003, Pages 1165-1170

  Elhendy, Abdou ^a   Schinkel, Arend F L ^b   Van Domburg, Ron T ^b   Bax, Jeroen J ^b   Poldermans, Don ^b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; FIXED HEART MUSCLE PERFUSION ABNORMALITY; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

EID: 0242408914     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.07.024     Document Type: Article

References (22)

1. Ritchie J.L., Bateman T.M., Bonow R.O., Crawford M.H., Gibbons R.J., Hall R.J., O'Rourke R.A., Parisi A.F., Verani M.S. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol. 25:1995;521-547.
2. Beller G.A., Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 101:2000;1465-1478.
3. Baer F.M., Smolarz K., Theissen P., Voth E., Schicha H., Sechtem U. Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging . Eur Heart J. 15:1994;97-107.
4. Kang X., Germano G., Berman D.S. Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT prognostic value and impact on referral to early catheterization . J Nucl Cardiol. 9:2002;23-32.
5. Aboul-Enein F.A., Berman D.S., Hayes S.W., Schisterman E., Friedman J., Germano G. Do nonreversible defects affect risk of cardiac death in chronic coronary artery disease? J Am Coll Cardiol. 39:(suppl 2):2002;343.
6. DePuey E.G., Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 36:1995;952-955.
7. Yao S.S., Nichols K., DePuey E.G., Rozanski A. Detection of occult left ventricular dysfunction in patients without prior clinical history of myocardial infarction by technetium-99m sestamibi myocardial perfusion gated single-photon emission computed tomography. Clin Cardiol. 25:2002;429-435.
8. Lumley M.A., Torosian T., Rowland L.L., Ketterer M.W., Pickard S.D. Correlates of unrecognized acute myocardial infarction detected via perfusion imaging. Am J Cardiol. 79:1997;1170-1173.
9. Hendel R.C., Parker M.A., Wackers F.J., Rigo P., Lahiri A., Zaret B.L. Reduced variability of interpretation and improved image quality with a technetium 99m-labelled tetrofosmin. J Nucl Cardiol. 1:1994;509-514.
10. Brown K.A. Prognostic value of myocardial perfusion imaging state of the art and new developments . J Nucl Cardiol. 3:1996;516-537.
11. Iskander S., Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol. 32:1998;57-62.
12. Geleijnse M.L., Elhendy A., van Domburg R.T., Cornel J.H., Reijs A.E., Roelandt J.R., Krenning E.P., Fioretti P.M. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol. 28:1996;447-454.
13. Berman D.S., Hachamovitch R., Kiat H., Cohen I., Cabico J.A., Wang F.P., Friedman J.D., Germano G., Van Train K., Diamond G.A. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography . J Am Coll Cardiol. 26:1995;639-647.
14. Calnon D.A., McGrath P.D., Doss A.L., Harrell F.E., Watson D.D., Beller G.A. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging stratification of a high-risk population . J Am Coll Cardiol. 38:2001;1511-1517.
15. Diamond G.A., Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 300:1979;1350-1358.
16. Elhendy A., van Domburg R.T., Sozzi F.B., Poldermans D., Bax J.J., Roelandt J.R. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart. 85:2001;655-661.
17. Elhendy A., Valkema R., van Domburg R.T., Bax J.J., Nierop P.R., Cornel J.H., Geleijnse M.L., Reijs A.E., Krenning E.P., Roelandt J.R. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med. 39:1998;1662-1666.
18. Santiago J.F., Heiba S.I., Jana S., Mirzaitehrane M., Dede F., Abdel-Dayem H.M. Transient ischemic stunning of the myocardium in stress thallium-201 gated SPECT myocardial perfusion imaging segmental analysis of myocardial perfusion, wall motion and wall thickening changes . Eur J Nucl Med Mol Imaging. 29:2002;979-983.
19. Miller G.L., Herman S.D., Heller G.V., Kalla S., Levin W.A., Stillwell K.M., Travin M.I. Relation between perfusion defects on stress technetium-99m sestamibi SPECT scintigraphy and the location of a subsequent acute myocardial infarction. Am J Cardiol. 78:1996;26-30.
20. Cabin H.S., Roberts W.C. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ("silent") previous acute myocardial infarction. Am J Cardiol. 50:1982;677-681.
21. Lauer M.S., Blackstone E.H., Young J.B., Topol E.J. Cause of death in clinical research time for a reassessment? J Am Coll Cardiol. 34:1999;618-620.
22. De Lorenzo A., Lima R.S., Siqueira-Filho A.G., Pantoja M.R. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 90:2002;827-832.